Skip to content
Main Navigation
About us
Company profile
Our values
Our strategy
Board of Directors
Senior management
Our history
Research and development
Technology platform
Therapeutic areas
Pipeline
Scientific papers and presentations
Partnering
Our approach
Our partnerships
Investors
Share information
Events & Presentations
Financial reports
Financial calendar
Shareholder meetings
Shareholder information
Analyst coverage
Corporate governance
ESG
Newsroom
Press Releases
Image library
Glossary
Careers
Search
Research and development
Scientific papers and presentations
Sharing our discoveries and developments in our tireless pursuit of breakthrough therapies
Newest first
Oldest first
Posters & Papers
Presentations
Search
Reset
01/07/2022
Keystone Symposium: Viral Immunity: Basic Mechanisms and Therapeutic Applications | Poster #: 1040 | A DNA COVID-19 vaccine candidate targeting antigen-presenting cell and adapted to RBD of emerging SARS-CoV-2 variants induced strong cross-neutralizing antibodies and protective immune responses in mice
21/04/2022
World Vaccine Congress | Using the Vaccibody™ platform to create new second and third generation vaccines against COVID
08/04/2022
2022 AACR | Poster #: 2232 | A novel and versatile cytokine empowered DNA vaccine platform with superior immune activating potential
22/03/2022
Keystone Symposium: Cancer Immunotherapy | Targeting Cancer Antigens to Antigen Presenting Cells to Elicit Rapid, Broad and Dominant CD8 T Cell Responses
08/03/2022
2022 AACR | Abstract #: 2332 | A novel and versatile cytokine empowered DNA vaccine platform with superior immune activating potential
Pages:
1
2
3
4
5
6
7
8
9
10
Load more
Sorry, nothing found in this query
Privacy statement
Cookie policy
Disclaimer
